Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background: Mitochondria are intracellular organelles of bacterial origin capable of stimulating the immune system when released into the extracellular milieu. We previously reported the expression of anti-mitochondrial antibodies (AMA) targeting whole organelles (AwMA), mitochondrial DNA (AmtDNA) or mitochondrial RNA (AmtRNA) in patients with systemic lupus erythematosus (SLE). Antiphospholipid syndrome (APS) is an autoimmune condition that may be independent of, or associated with, other diseases, usually SLE. This study aimed to detect AMA in patients with APS and to explore the association with clinical features of APS. Methods: AwMA-, AmtDNA- and AmtRNA-IgG and -IgM were detected in a pilot study (healthy controls n = 30 and APS patients n = 24) by direct ELISA, and their levels were associated with demographic and disease characteristics. Results: AmtDNA-IgM and AmtRNA-IgG and IgM were elevated in APS compared to healthy controls ( p = 0.009, p = 0.0005 and p = 0.01, respectively). AwMA-IgG were increased in patients positive for lupus anticoagulant (median ± interquartile range = 0.36 ± 0.31 vs. 0.14 ± 0.08, p = 0.008), and optical density values for AwMA-IgM were correlated with titres of IgM against cardiolipin ( r s = 0.51, p = 0.01). An increment of 0.1 unit of AmtDNA-IgM levels was associated with reduced prior reporting of arterial events (odds ratio = 0.86; 95% confidence interval 0.74–1.00; p = 0.047). Conclusion: Our pilot study suggests that AMA are represented within the autoantibody repertoire in APS and may display different associations with the clinical manifestations of the disease. Further studies should focus on reproducing these preliminary results by following AMA levels through time in larger prospective cohorts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both IgG and IgM antibodies that target mtRNA (anti-mtRNA antibodies) are present at higher titres in patients with SLE or APS than in healthy individuals; in patients with SLE, higher titres of anti-mtRNA IgG antibodies are associated with a lower occurrence of carotid plaque and lupus nephritis231,261.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [261]
In the citing paper
“Immunoreactivity to intact mitochondria (owing to the presence of anti-whole mitochondria antibodies) is increased in the sera of patients with SLE compared with that of healthy individuals and is associated with increased disease activity230,261,262.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [261]
In the citing paper
“Antibodies to mitochondrial nucleic acids (mtDNA and mtRNA) are also present in patients with SLE or APS230,231,261,262.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [261]
In the citing paper
“Naturally occurring mitochondrial antibodies are thought to enhance the clearance of mitochondrial components released during cell death and apoptosis63, as indicated by the various negative associations between levels of autoantibodies to mitochondria and clinical parameters of several diseases231,261,269.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [261]
In the citing paper
“Similarly, patients with APS have higher titres of anti-mtDNA IgM antibodies than healthy individuals; however, in these patients, increased anti-mtDNA IgM antibodies titres was associated with a decreased likelihood of having a history of arterial thrombosis, although these findings need to be confirmed in more patients261.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [261]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570
Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,543 · cited 1×
“Various phospholipids are recognized by aPL, and can be detected by clinical assays such as lupus anticoagulant (LA), anti-beta-2glycoprotein I (anti-b2GPI) and anticardiolipin (aCL) antibodies.(10) aCL (also known as AMA-M1) and AMA-M5(8) are two AMA that have been detected in the APS autoantibody repertoire.”
BackgroundUpdate of the guidelines for lupus anticoagulant detection
PENGO, V., TRIPODI, A., REBER, G., RAND, J. H., ORTEL, T. L., GALLI, M., & DE GROOT, P. G. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03555.x · Cited by 1,197 · cited 1×
“Information obtained from analyses performed at our clinical laboratory as part of routine care included detection of IgG and IgM against CL (using a cut-off of 40 UPL) and b2-GPI (using a cut-off above the 99th percentile of controls) by ELISA, and LA assays were performed following international guidelines.(12) AMA…”
MethodBoudreau, L. H., Duchez, A.-C., Cloutier, N., Soulet, D., Martin, N., Bollinger, J., Paré, A., Rousseau, M., Naika, G. S., Lévesque, T., et al. (2014) · Blood · doi:10.1182/blood-2014-05-573543 · Cited by 703 · cited 1×
“While mitochondria are cytoplasmic organelles under normal circumstances, they may also be extruded into the extracellular milieu upon the activation of many cell lineages or following tissue damage.(2,3) Extracellular mitochondria with preserved morphology and functionality or mitochondrial components (e.”
BackgroundSelf-citationEmerging role of damage-associated molecular patterns derived from mitochondria in inflammation
Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., & Vandenabeele, P. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.005 · Cited by 680 · cited 3×
“Mitochondria are considered as descending from the endosymbiosis between an a-proteobacterion and a primitive eukaryotic cell,(2) conferring the organelle several molecular motifs that are specific to bacteria.(2) (1)Centre de Recherche ARThrite – Arthrite, Recherche et Traitements, Universit e Laval, Quebec, Canada (…”
BackgroundInfluentialMarcoux, G., Magron, A., Sut, C., Laroche, A., Laradi, S., Hamzeh‐Cognasse, H., Allaeys, I., Cabon, O., Julien, A., Garraud, O., et al. (2019) · Transfusion · doi:10.1111/trf.15300 · Cited by 87
Self-citationTuominen, A., Miller, Y. I., Hansen, L. F., Kesäniemi, Y. A., Witztum, J. L., & Hörkkö, S. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000233333.07991.4a · Cited by 78 · cited 1×
“apoptosomes displaying CL on their surface).(15) We postulate that the auto-immunization processes occurring during the pathophysiology leading to Becker et al.”
BackgroundBecker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40900-3 · Cited by 75 · cited 10×
“mitochondrial DNA (mtDNA)) have been detected in platelet concentrates used for transfusion(4,5) as well as in various conditions.(2,6,7) Mitochondria are considered as descending from the endosymbiosis between an a-proteobacterion and a primitive eukaryotic cell,(2) conferring the organelle several molecular motifs t…”
BackgroundMethodSelf-citationMarcoux, G., Duchez, A.-C., Rousseau, M., Lévesque, T., Boudreau, L. H., Thibault, L., & Boilard, E. (2017) · Platelets · doi:10.1080/09537104.2016.1218455 · Cited by 71
Self-citation
Cited by
The role of platelets in immune-mediated inflammatory diseases
Scherlinger, M., Richez, C., Tsokos, G. C., Boilard, E., & Blanco, P. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00834-4 · Cited by 346
Self-citationAntimitochondrial Antibodies: from Bench to Bedside
Colapietro, F., Lleò, A., & Generali, E. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08904-y · Cited by 95
“In particular, anti-DNA-IgM were associated with a lower likelihood of reporting a previous arterial thrombosis, and their levels were not influenced by the duration of the disease, cardiovascular risk factors or medications [75].”
BackgroundThe role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Self-citationPlatelet extracellular vesicles and the secretory interactome join forces in health and disease
Boilard, É., & Bellio, M. (2022) · Immunological Reviews · doi:10.1111/imr.13119 · Cited by 35
Self-citationZhao, Y., Wu, C., Liang, X., & Yang, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1640748 · Cited by 30
Metadata
- Authors
- Becker, Y. L., Julien, A.-S., Godbout, A., Boilard, É., & Fortin, P. R.
- Affiliations
- Université Laval (CA)
- Centre de recherche du CHU de Québec-Université Laval (CA)
- Corresponding author
- Fortin, Paul R
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2020-08-12
- Volume
- 29
- Issue
- 12
- Pages
- 1623-1629
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W3049019850
- Cited by
- 11
- References
- 15
- Citations by year
- 2026: 3 · 2025: 3 · 2023: 1 · 2022: 3 · 2021: 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (Foundation Grant 331668)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- antimitochondrial antibodies, antiphospholipid syndrome, lupus anticoagulant, anticardiolipin antibodies, arterial events, autoantibody repertoire, systemic lupus erythematosus
- MeSH terms
- RNA, Mitochondrial, Adult, Aged, Autoantibodies, DNA, Mitochondrial, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Mitochondria, Pilot Projects, Logistic Models, Case-Control Studies, Antiphospholipid Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome. https://app.cochat.ai/papers/10.1177/0961203320944481
- The paper
- Becker, Y. L., Julien, A.-S., Godbout, A., Boilard, É., & Fortin, P. R. (2020). Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome. Lupus. https://doi.org/10.1177/0961203320944481
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.